These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7126224)

  • 1. Amino acid hydroxamates as inhibitors of the human enkephalin-degrading aminopeptidase.
    Coletti-Previero MA; Crastes de Paulet A; Mattras H; Previero A
    Biochem Biophys Res Commun; 1982 Jul; 107(2):465-9. PubMed ID: 7126224
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of enkephalin-degrading enzymes from rat brain and of thermolysin by amino acid hydroxamates.
    Blumberg S; Vogel Z; Altstein M
    Life Sci; 1981 Jan; 28(3):301-6. PubMed ID: 7012516
    [No Abstract]   [Full Text] [Related]  

  • 3. Hydroxamates and aliphatic boronic acids: marker inhibitors for aminopeptidase.
    Baker JO; Wilkes SH; Bayliss ME; Prescott JM
    Biochemistry; 1983 Apr; 22(9):2098-103. PubMed ID: 6860652
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of aminopeptidases by N-aminoacyl-O-4-nitrobenzoyl hydroxamates.
    Demuth HU; Stöckel A; Schierhorn A; Fittkau S; Kirschke H; Brömme D
    Biochim Biophys Acta; 1993 Oct; 1202(2):265-70. PubMed ID: 8399389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'In vivo' amplification of biological activity of tetragastrin by amino acid hydroxamates.
    Bali JP; Mattras H; Previero A; Coletti-Previero MA
    Biosci Rep; 1984 Dec; 4(12):1009-15. PubMed ID: 6529604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereospecificity of amino acid hydroxamate inhibition of aminopeptidases.
    Wilkes SH; Prescott JM
    J Biol Chem; 1983 Nov; 258(22):13517-21. PubMed ID: 6643439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of leucine aminopeptidase by amino acid hydroxamates.
    Chan WW; Dennis P; Demmer W; Brand K
    J Biol Chem; 1982 Jul; 257(14):7955-7. PubMed ID: 7085655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bidentate peptides: highly potent new inhibitors of enkephalin degrading enzymes.
    Bouboutou R; Waksman G; Devin J; Fournié-Zaluski MC; Roques BP
    Life Sci; 1984 Aug; 35(9):1023-30. PubMed ID: 6088932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enkephalin-degrading aminopeptidase in the longitudinal muscle layer of guinea pig small intestine: its properties and action on neuropeptides.
    Shimamura M; Hazato T; Iwaguchi T
    J Biochem; 1991 Mar; 109(3):492-7. PubMed ID: 1679058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of endogenous enkephalin degradation from peptidases in human serum by actinonin.
    Nakajima S; Kaya K; Hazato T
    Neuropeptides; 1989 Apr; 13(3):201-6. PubMed ID: 2710293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery of rat nasal mucosa from the effects of aminopeptidase inhibitors.
    Hussain MA; Koval CA; Shenvi AB; Aungst BJ
    J Pharm Sci; 1990 May; 79(5):398-400. PubMed ID: 2352157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of the enkephalin degrading enzymes. Modulation of activity of hydroxamate containing compounds by modifications of the C-terminal residue.
    Xie J; Soleilhac JM; Renwart N; Peyroux J; Roques BP; Fournié-Zaluski MC
    Int J Pept Protein Res; 1989 Sep; 34(3):246-55. PubMed ID: 2574715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHR-2797: an antiproliferative aminopeptidase inhibitor that leads to amino acid deprivation in human leukemic cells.
    Krige D; Needham LA; Bawden LJ; Flores N; Farmer H; Miles LE; Stone E; Callaghan J; Chandler S; Clark VL; Kirwin-Jones P; Legris V; Owen J; Patel T; Wood S; Box G; Laber D; Odedra R; Wright A; Wood LM; Eccles SA; Bone EA; Ayscough A; Drummond AH
    Cancer Res; 2008 Aug; 68(16):6669-79. PubMed ID: 18701491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of aminopeptidases from Aplysia californica.
    Bawab W; Querido E; Crine P; DesGroseillers L
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):967-75. PubMed ID: 1417757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Some features of enkephalin metabolism in the rat brain after administration of bestatin].
    Beliaev NA; Kolesanova EF; Baronets VIu; Panchenko LF
    Biokhimiia; 1993 Jul; 58(7):1033-46. PubMed ID: 8364122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxamate-induced spectral perturbations of cobalt Aeromonas aminopeptidase.
    Wilkes SH; Prescott JM
    J Biol Chem; 1987 Jun; 262(18):8621-5. PubMed ID: 3597389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial purification of two distinct enkephalin-degrading aminopeptidases from human cerebrospinal fluid.
    Hazato T; Shimamura M; Komuro T; Katayama T
    Biochem Int; 1985 May; 10(5):813-9. PubMed ID: 2409980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Leu-enkephalin homogeneously labeled with tritium in studying the Selank inhibiting effect on the enkephalin-degrading enzymes of human plasma].
    Zolotarev IuA; Sokolov OIu; Kost NV; Vas'kovskiĭ BV; Miasoedov NF; Zozulia AA
    Bioorg Khim; 2004; 30(3):234-40. PubMed ID: 15344652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of the aminopeptidase inhibitor bestatin on the enkephalin level in the rat brain].
    Beliaev NA; Kolesanova EF; Kelesheva LF; Rotanova TV; Panchenko LF
    Biull Eksp Biol Med; 1990 Nov; 110(11):474-5. PubMed ID: 2083325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-Carboline and diazepam effect on the degradation of enkephalin by the human blood aminopeptidase.
    Coletti-Previero MA; Mattras H; Previero A
    Biosci Rep; 1983 Jan; 3(1):87-92. PubMed ID: 6301578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.